{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:42:44Z","timestamp":1772134964196,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T00:00:00Z","timestamp":1761436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T00:00:00Z","timestamp":1761436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41433-025-04080-x","type":"journal-article","created":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T04:58:13Z","timestamp":1761454693000},"page":"45-50","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-vascular endothelial growth factor for the management of peripapillary choroidal neovascular membrane"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6233-9806","authenticated-orcid":false,"given":"Angelica","family":"Hanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aswen","family":"Sriranganathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kertes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Yau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,26]]},"reference":[{"key":"4080_CR1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1755-3768.1994.tb02749.x","volume":"72","author":"S Ruben","year":"1994","unstructured":"Ruben S, Palmer H, Marsh RJ. The visual outcome of peripapillary choroidal neovascular membranes. Acta Ophthalmol (Copenh). 1994;72:118\u201321.","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"4080_CR2","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1097\/IAE.0000000000001710","volume":"38","author":"P D\u2019souza","year":"2018","unstructured":"D\u2019souza P, Ranjan R, Babu U, Kanakath AV, Saravanan VR. INFLAMMATORY CHOROIDAL NEOVASCULAR MEMBRANE: Long-Term Visual and Anatomical Outcomes After Intravitreal Anti\u2013vascular Endothelial Growth Factor Therapy. RETINA. 2018;38:1307\u201315.","journal-title":"RETINA"},{"key":"4080_CR3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/eye.2011.24","volume":"25","author":"G Jutley","year":"2011","unstructured":"Jutley G, Tah V, Lindfield D, Menon G. Treating peripapillary choroidal neovascular membranes: a review of the evidence. Eye (Lond). 2011;25:675\u201381.","journal-title":"Eye (Lond)"},{"key":"4080_CR4","doi-asserted-by":"crossref","unstructured":"Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ Etiology of Choroidal Neovascularization in Young Patients. Ophthalmology. 1996;103:1241\u20134.","DOI":"10.1016\/S0161-6420(96)30515-0"},{"key":"4080_CR5","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.ophtha.2004.11.062","volume":"112","author":"DJ Browning","year":"2005","unstructured":"Browning DJ, Fraser CM. Ocular conditions associated with peripapillary subretinal neovascularization, their relative frequencies, and associated outcomes. Ophthalmology. 2005;112:1054\u201361.","journal-title":"Ophthalmology"},{"key":"4080_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/00006982-199212020-00012","volume":"12","author":"PF Lopez","year":"1992","unstructured":"Lopez PF, Green WR. Peripapillary subretinal neovascularization. A review. Retina. 1992;12:147\u201371.","journal-title":"Retina"},{"key":"4080_CR7","doi-asserted-by":"crossref","unstructured":"Wilde C, Poostchi A, Mehta RL, Hillman JG, MacNab HK, Messina M, et al. Prevalence of peripapillary choroidal neovascular membranes (PPCNV) in an elderly UK population\u2014the Bridlington eye assessment project (BEAP): a cross-sectional study (2002\u20132006). Eye. 2018;33:451\u20138.","DOI":"10.1038\/s41433-018-0232-y"},{"key":"4080_CR8","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1097\/IAE.0000000000002272","volume":"39","author":"T Lin","year":"2019","unstructured":"Lin T, Dans K, Meshi A, Muftuoglu IK, Amador-Patarroyo MJ, Chen KC, et al. Age-Related Macular Degeneration-Associated Peripapillary Choroidal Neovascularization in the Era of Anti-Vascular Endothelial Growth Factor Therapy. Retina. 2019;39:1936\u201344.","journal-title":"Retina"},{"key":"4080_CR9","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1136\/bjo.2008.144196","volume":"92","author":"MS Figueroa","year":"2008","unstructured":"Figueroa MS, Noval S, Contreras I. Treatment of peripapillary choroidal neovascular membranes with intravitreal bevacizumab. British J Ophthalmol. 2008;92:1244.","journal-title":"British J Ophthalmol"},{"key":"4080_CR10","unstructured":"Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. (2689-8381 (Electronic))."},{"key":"4080_CR11","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available from: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"4080_CR12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1159\/000520930","volume":"245","author":"G Rabina","year":"2021","unstructured":"Rabina G, Ayalon A, Mimouni M, Stanescu N, Moisseiev E, Nemet AY, et al. Optical Coherence Tomography Prognostic Factors in Age-Related Macular Degeneration Patients with Peripapillary Choroidal Neovascularization. Ophthalmologica. 2021;245:342\u20139.","journal-title":"Ophthalmologica"},{"key":"4080_CR13","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1136\/bjophthalmol-2019-314542","volume":"104","author":"SR Singh","year":"2020","unstructured":"Singh SR, Fung AT, Fraser-Bell S, Lupidi M, Mohan S, Gabrielle P-H, et al. One-year outcomes of anti-vascular endothelial growth factor therapy in peripapillary choroidal neovascularisation. British J Ophthalmol. 2020;104:678.","journal-title":"British J Ophthalmol"},{"key":"4080_CR14","doi-asserted-by":"crossref","unstructured":"Aisenbrey S, Gelisken F. Surgical treatment of peripapillary choroidal neovascularisation. Br J Ophthalmol. 2007;91:1027\u201330.","DOI":"10.1136\/bjo.2006.108118"},{"key":"4080_CR15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00417-003-0686-9","volume":"241","author":"F Bandello","year":"2003","unstructured":"Bandello F, Lanzetta P, Battaglia Parodi M, Roman-Pognuz D, Saviano S, Ravalico G. Photodynamic therapy of subfoveal recurrences after laser photocoagulation of extrafoveal choroidal neovascularization in pathologic myopia. Graefes Arch Clin Exp Ophthalmol. 2003;241:567\u201370.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4080_CR16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/eye.2015.251","volume":"30","author":"DK Newman","year":"2016","unstructured":"Newman DK. Photodynamic therapy: current role in the treatment of chorioretinal conditions. Eye (Lond). 2016;30:202\u201310.","journal-title":"Eye (Lond)"},{"key":"4080_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00006982-200306000-00001","volume":"23","author":"BG Busbee","year":"2003","unstructured":"Busbee BG, Brown MM, Brown GC, Sharma S. CME review: A cost-utility analysis of laser photocoagulation for extrafoveal choroidal neovascularization. Retina. 2003;23:279\u201387.","journal-title":"Retina"},{"key":"4080_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/112067210901900128","volume":"19","author":"AE Hoeh","year":"2009","unstructured":"Hoeh AE, Schaal KB, Ach T, Dithmar S. Treatment of Peripapillary Choroidal Neovascularization with Intravitreal Bevacizumab. European J Ophthalmol. 2009;19:163\u20135.","journal-title":"European J Ophthalmol"},{"key":"4080_CR19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ajo.2008.05.024","volume":"146","author":"AM Mansour","year":"2008","unstructured":"Mansour AM, Mackensen F, Arevalo JF, Ziemssen F, Mahendradas P, Mehio-Sibai A, et al. Intravitreal Bevacizumab in Inflammatory Ocular Neovascularization. American J Ophthalmol. 2008;146:410\u20136.e1.","journal-title":"American J Ophthalmol"},{"key":"4080_CR20","doi-asserted-by":"crossref","unstructured":"Ozgonul C, Moinuddin O, Munie M, Lee MS, Bhatti MT, Landau K, et al. Management of Peripapillary Choroidal Neovascular Membrane in Patients With Idiopathic Intracranial Hypertension. J Neuro-Ophthalmol. 2019;39:451\u20137.","DOI":"10.1097\/WNO.0000000000000781"},{"key":"4080_CR21","doi-asserted-by":"crossref","unstructured":"Roy R, Saurabh K, Bansal A, Kumar A, Majumdar AK, Paul SS. Inflammatory choroidal neovascularization in Indian eyes: Etiology, clinical features, and outcomes to anti-vascular endothelial growth factor. Indian J Ophthalmol. 2017;65:295\u2013300.","DOI":"10.4103\/ijo.IJO_262_16"},{"key":"4080_CR22","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s41433-022-02089-0","volume":"37","author":"N Stanescu","year":"2023","unstructured":"Stanescu N, Friehmann A, Nemet A, Keshet Y, Ohayon A, Greenbaum E, et al. Long-term outcomes of anti-vascular endothelial growth factor treatment in peripapillary choroidal neovascularisation due to age-related macular degeneration. Eye. 2023;37:1202\u20136.","journal-title":"Eye"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04080-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04080-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04080-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T17:04:01Z","timestamp":1767459841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04080-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,26]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4080"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-04080-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5645654\/v1","asserted-by":"object"}]},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,26]]},"assertion":[{"value":"14 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}